Anthony E. Cassella Jr.
Known title: EVP of Finance & CAOCIK: 0001622146
Associated companies
Transaction History
| HZO | ▲ Buy | Option Exercise | 5,885 | $0 | 9/30/2026 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,495 | $0 | 9/30/2026 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,628 | $0 | 9/30/2026 | View on chart |
| HZO | ▲ Buy | Option Exercise | 2,343 | $0 | 9/30/2026 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 2,766 | $145K | 9/30/2026 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,627 | $0 | 9/30/2025 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 2,236 | $57K | 9/30/2025 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,495 | $0 | 9/30/2025 | View on chart |
| HZO | ▲ Buy | Option Exercise | 242 | $0 | 9/30/2025 | View on chart |
| HZO | ▲ Buy | Option Exercise | 4,820 | $0 | 9/30/2025 | View on chart |
| HZO | ▲ Buy | Option Exercise | 983 | $0 | 9/30/2025 | View on chart |
| HZO | ▼ Sell | Open Market | 4,000 | $124K | 1/27/2025 | View on chart |
| HZO | ▲ Buy | Option Exercise | 3,777 | $0 | 9/30/2024 | View on chart |
| HZO | ▲ Buy | Option Exercise | 982 | $0 | 9/30/2024 | View on chart |
| HZO | ▲ Buy | Option Exercise | 242 | $0 | 9/30/2024 | View on chart |
| HZO | ▲ Buy | Option Exercise | 480 | $0 | 9/30/2024 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,494 | $0 | 9/30/2024 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 1,700 | $60K | 9/30/2024 | View on chart |
| HZO | ▼ Sell | Open Market | 5,000 | $161K | 2/15/2024 | View on chart |
| HZO | ▲ Buy | Option Exercise | 4,931 | $0 | 9/30/2023 | View on chart |
| HZO | ▲ Buy | Option Exercise | 627 | $0 | 9/30/2023 | View on chart |
| HZO | ▲ Buy | Option Exercise | 480 | $0 | 9/30/2023 | View on chart |
| HZO | ▲ Buy | Option Exercise | 242 | $0 | 9/30/2023 | View on chart |
| HZO | ▲ Buy | Option Exercise | 981 | $0 | 9/30/2023 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 1,769 | $58K | 9/30/2023 | View on chart |
| HZO | ▼ Sell | Open Market | 5,000 | $155K | 2/8/2023 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 259 | $8K | 9/30/2022 | View on chart |
| HZO | ▲ Buy | Option Exercise | 626 | $0 | 9/30/2022 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 153 | $5K | 9/30/2022 | View on chart |
| HZO | ▲ Buy | Option Exercise | 5,804 | $0 | 9/30/2022 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 1,414 | $42K | 9/30/2022 | View on chart |
| HZO | ▲ Buy | Option Exercise | 479 | $0 | 9/30/2022 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 117 | $3K | 9/30/2022 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,063 | $0 | 9/30/2022 | View on chart |
| HZO | ▼ Sell | Open Market | 8,096 | $463K | 12/15/2021 | View on chart |
| HZO | ▼ Sell | Open Market | 904 | $52K | 12/10/2021 | View on chart |
| HZO | ▲ Buy | Option Exercise | 1,062 | $0 | 9/30/2021 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 259 | $13K | 9/30/2021 | View on chart |
| HZO | ▲ Buy | Option Exercise | 626 | $0 | 9/30/2021 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 153 | $7K | 9/30/2021 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 1,181 | $57K | 9/30/2021 | View on chart |
| HZO | ▲ Buy | Option Exercise | 4,849 | $0 | 9/30/2021 | View on chart |
| HZO | ▲ Buy | Option Exercise | 845 | $0 | 9/30/2021 | View on chart |
| HZO | ▼ Sell | Tax Withholding | 206 | $10K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
MarineMax featured in skeptical stock list
MarineMax was included in a Yahoo Finance article highlighting three profitable stocks that the authors view with skepticism. The piece suggests caution regarding the company's valuation despite its earnings. This mention adds a layer of debate around the stock's current price relative to its fundamentals.
MarineMax featured in skeptical stock list. MarineMax was included in a Yahoo Finance article highlighting three profitable stocks that the authors view with skepticism. The piece suggests caution regarding the company's valuation despite its earnings. This mention adds a layer of debate around the stock's current price relative to its fundamentals.